Article Hero

Remdesivir: the first COVID-19 drug to obtain formal clearance from the FDA

1603452467.jpg
Miguel A. Rodriguez
Miguel A. Rodriguez
23 octubre 2020
Remdesivir "is now the first and only approved covid-19 treatment in the U.S."

After being one of the frontrunners in finding a viable COVID-19 vaccine, Gilead passed a new milestone.

The continuous promising results made the U.S. Food and Drug Administration approve Gilead's antiviral Remdesivir. It is the first drug of its kind to receive formal clearance to treat COVID-19 infected patients.

The medicine’s approval comes after earlier this year it was granted an emergency use authorization to be administrated to hospitalized patients. It will be sold under the name of Veklury. Moreover, President Trump underwent the treatment when he was found positive for COVID-19 infection. However, according to a report from the World Health Organization, Remdesivir didn't reduce the death toll caused by the virus.

"Veklury is now the first and only approved Covid-19 treatment in the United States," read Gilead's statement. Moreover, if in the beginning, the drug was shot on supply, now, the manufacturing capacity has expanded.

Following the report, Gilead's stock price gained 0.76%. In today's pre-market trading, it went up more than 5.50%.

Sources: thestreet.com, Bloomberg.com

disclaimers_articles

article_share_title

article_rating_title

awful
ok
great
awesome

read_more

Miguel A. Rodriguez
Miguel A. Rodriguez
financial_writer

Miguel comenzó su destacada carrera profesional en reputadas instituciones financieras como el Banco Santander y el Banco Central-Hispano. Es autor de importantes libros sobre trading en el mercado de divisas.